BioSpace News Archive

NanoViricides, Inc. today announced it will be featured as a presenting company at the Biotech ShowcaseTM Investor Conference.

Ionis Pharmaceuticals, Inc. today announced that Management will present a Company overview at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 4:00 p.m. PT in San Francisco, CA.

Dr. Shigeru Saito Treats First Patient at Shonan Kamakura General Hospital

Results are expected in the second half of 2019

First-of-its-kind study designed to demonstrate safety and efficacy of the Tack Endovascular System® in treating post-PTA dissections below the knee

Eagle Pharmaceuticals, Inc. today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference

AVEO Oncology today announced that data from the Phase 3 TIVO-3 study of tivozanib (FOTIVDA®) versus sorafenib in refractory advanced or metastatic renal cell carcinoma (RCC) will be presented during an oral session at the 2019 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium being held February 14-16, 2019 in San Francisco.

Akebia Therapeutics, Inc. today announced that its President and Chief Executive Officer, John P. Butler, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 9:30 a.m. Pacific Time at the Westin St. Francis in San Francisco.

Viking Therapeutics, Inc. today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at the 11th Annual Biotech Showcase™, being held January 7-9, 2019 at the Hilton San Francisco Union Square in San Francisco.

Expanding its national footprint to Florida, The Columbus Organization, a leading provider of care coordination services for individuals with Intellectual and Developmental Disabilities, today announced that the company has acquired Support Associates of Tampa Bay.